Akero Therapeutics, Inc. - AKRO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 23
Latest filed: Feb 17, 2026
Form Count
4 17
SCHEDULE 13G/A 4
8-K 2

Latest files

Filed Form Report period Accession SEC
Feb 17, 2026 SCHEDULE 13G/A 0001493215-26-000022 View
Feb 17, 2026 SCHEDULE 13G/A 0001274173-26-000064 View
Feb 13, 2026 SCHEDULE 13G/A 0001172661-26-000709 View
Feb 10, 2026 SCHEDULE 13G/A 0000902219-26-000090 View
Dec 09, 2025 8-K Dec 09, 2025 0001140361-25-044946 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312092 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312098 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312099 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312100 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312109 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312111 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312115 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312116 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312121 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312122 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312127 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312131 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312133 View
Dec 09, 2025 4 Dec 09, 2025 0001193125-25-312134 View
Dec 03, 2025 8-K Dec 02, 2025 0001140361-25-044131 View
Nov 28, 2025 4 Nov 25, 2025 0001193125-25-301155 View
Nov 26, 2025 4 Nov 24, 2025 0001193125-25-300488 View
Nov 21, 2025 4 Nov 20, 2025 0001193125-25-291688 View